CHOLESTEROL ABSORPTION INHIBITION: THE FUTURE OF LIPID MANAGEMENT
Educational Symposium sponsored by MSD-SP Limited
| Chairpersons: | G. Assmann, Germany J. Shepherd, UK |
|
| 12:00 | INTRODUCTION J. Sheperd, UK |
|
| 12:10-12:30 | ESTABLISHING A NEW PARADIGM IN CHOLESTEROL
MANAGEMENT G. Assmann, Germany |
|
| 12:30-12:50 | THE BENEFITS OF TARGETING THE EXOGENOUS
CHOLESTEROL METABOLISM PATHWAY IN THE TREATMENT OF LIPID DISORDERS
L. Badimon, Spain |
|
| 12:50-13:10 | CLINICAL EXPERIENCE WITH, EZETIMIBE, THE
FIRST IN A NEW CLASS OF CHOLESTEROL ABSORPTION INHIBITORS J. Shepherd, UK |
|
| 13:10-13:30 | EZETIMIBE: SHAPING THE FUTURE OF DYSLIPIDEMIA
TREATMENT J. Kastelein, The Netherlands |
|
| 13:30-13:55 | Discussion | |
| 13:55-14:00 |
CLOSING REMARKS |
